期刊文献+

小儿心肌炎基质金属蛋白酶-1检测及其意义 被引量:1

The measurement and clinical significance of matrix metalloproteinase-1 in children with myocarditis
下载PDF
导出
摘要 目的评价血液中基质金属蛋白酶-1(MMP—1)与小儿心肌炎相互关系,验证临床检测MMP-1的意义。方法将年龄为1—14岁临床诊断为心肌炎的患者9例与相匹配的对照组9例取血标本,测定心肌酶谱包括门冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)、肌酸激酶(CK)、α-羟丁酸脱氢酶(HBDH)、肌酸激酶同工酶(CKMB),心肌肌钙蛋白I(cTnI)、C反应蛋白及MMP-1,并行超声心动图等检查。结果超声心动图示心肌炎患儿射血分数显著降低、左心室扩大。心肌炎患儿与正常对照组心肌酶、心肌肌钙蛋白I、C反应蛋白及MMP-1检测差异均无显著性。结论对少儿心肌炎患者来说,血液中的MMP-1水平可能与其疾病无相关性。 Objective To evaluate the relationship between serum matrix metalloproteinase - 1 and childhood myocarditis, and to provide evidences to support the measurement of serum matrix metalloproteinase - 1. Methods Matrix metalloproteinase - 1 and biochemical indexes of the harvested specimens and eehocardiogram were studied from children with myocarditis (age: 1 - 14 years old, n =9) and healthy young children (age: 1 - 14 years old, n =9). Results Children with myocarditis showed reduced ejection fraction and dilated left ventrieular compared with healthy children. Aspattie acid transaminase, lactate dehydrogenase, ereatine kinase, hydroxybutyrie acid dehydrogenase, MB isoenzyme of ereatine kinase, cardiac troponin I, C reactive protein and matrix metalloproteinase - 1 showed nosignifieant difference between the two groups. Conclusion Serum matrix Metalloproteinase - 1 is not associated with children myocarditis.
出处 《广东医学》 CAS CSCD 北大核心 2008年第3期414-416,共3页 Guangdong Medical Journal
基金 广东省深圳市科技计划项目(编号:JH20050712844A)
关键词 MMP-1 心肌炎 少儿 Matrix metalloproteinase - 1 Myocarditis Children
  • 相关文献

参考文献16

  • 1ETOH T, JOFFS C, DESCHAMPS A I, et al. Myocardial and interstitial matrix metalloprotein activity after acute myocardial infarction in pigs[ J]. Am J Physiol Heart Circ Physiol, 2001, 281 ( 3 ) : H987 - H994.
  • 2SPIANLE F G, COKER M L, THOMAS C V, et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure [ J ]. Cire Res, 1998, 82 : 482 -499.
  • 3STRAUSS B H, ROBINSON R, BATCHELOR W B, et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproinase [ J]. Circ Res, 1996, 79 : 541 - 550.
  • 4MALIK N, GREENFIELD B W, WAHL A F, et al. Activation of human monocytes through CD40 induces matrix metalloproteinase [J]. J Immunol, 1996, 156:3 952 -3 960.
  • 5SCHNOBECK U, MACH F, SUKHOVA G K, et al. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T -lymphocytes[ J]. Cire Res, 1997, 81 : 448 -454.
  • 6WEBER K T, BRILLA C G. Pathyological hypertrophy and cardiac interstitium, fibrosis and rennin - angiotensin - aldosterone system[J]. Circulation, 1991, 83(6): 1 849-1 865.
  • 7吴铁吉.病毒性心肌炎诊断标准(修订草案)[J].中国实用儿科杂志,2000,15(5):315-315.
  • 8SPINALE F G. Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function[ J]. Physiol Rev, 2007, 87(4) : 1 285 - 1 342.
  • 9KASSIRI Z, KHOKHA R. Myocardial extra- cellular matrix and its regulation by metalloproteinases and their inhibitors [ J ]. Thromb Haemost, 2005, 93(2) : 212 -219.
  • 10SPINALE F G, COKER M L, HEUNG L J, et al. A matrix metalloproteinase induction/activation system exisits in the human left ventricular myocardium and is upregulates in heart failure [ J ]. Circulation, 2000, 102:1 944-1 949.

二级参考文献3

共引文献152

同被引文献11

  • 1周志斌,李小好,牛建平,蒋春,王思鸿,丁秋华.急性脑梗死患者血清基质金属蛋白酶-9、C-反应蛋白临床意义的研究[J].中国全科医学,2006,9(17):1414-1416. 被引量:10
  • 2Etoh T,Joffs C, Deschamps AI, et al. Myocardial and interstitial matrix metalloprotein activity after acute myocardial infarction in pigs. Am J Physiol Heart Circ Physiol, 2001, 281 ( 3 ) : H987- I-I994.
  • 3Spianle FG, Coker ML, Thomas CV, et al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure. Circ Res, 1998, 82:482-499.
  • 4Strauss BH, Robinson R, Batehelor WB, et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproinase. Circ Res, 1996,79:541-550.
  • 5Spinale FG. Myocardial matrix remodeling and the matrix metanoproteinases:influence on cardiac form and function. Physiol Rev, 2007,87(4) : 1285-1342.
  • 6Kassiri Z, Khokha R. Myocardial extra-cellular matrix and its regulation by metalloproteinases and their inhibitors. Thromb Haemost, 2005,93(2) :212-219.
  • 7Hoashi T, Kanodo T, Kikuchi K, et al. Differential.growth regulation in human melanoma cell lines by TIMP-1 and TIMP-2.BiochemBiophys Res Commun,2001,288(2):371-379.
  • 8Li YY, Feldrnan AM, Sun Y, et al. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation, 1998,98 : 1728-1734.
  • 9Roten L, Nemoto S, Simsic J, et al. Effects of gene deletion of the tissue inhibitor of the matrix metalloproteinsse type 1 (TIMP-1) on left ventrlcular geometry and function in mice. J Mol Cell Cardiol, 2000,32 : 109-120.
  • 10Cheung C, Luo H, Yanagawa B, et al. Matrix metanoproteinases and tissue inhibitors of metanoproteinases in coxsaekievirus-induced myocarditis. Cardiovase Pathol, 2006,15 (2) : 63-74.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部